There’s nothing like starting the new year with a new possibility. Following failures by scores of other researchers, Ian Lipkin and his new Serochip technology recently fingered the culprit behind the acute flaccid myeltis (AFM) outbreak that’s been...
EpicGenetics – a biotech firm in Los Angeles – is attempting an FM trifecta: produce a blood and genomic test and provide a treatment. EpicGenetics is trying to make a big splash in fibromyalgia. A Los Angeles biotech firm, they focused on producing...
A recent Australian study suggested an already FDA approved drug can revive the not so killer natural killer cells found in ME/CFS in the lab. If that finding translates to humans we’ll have a breakthrough in the one verified immune hole in ME/CFS – one...
Solve ME funds seven pilot studies on chronic fatigue syndrome (ME/CFS) in its 2019 Ramsay Awards The great thing about Solve ME’s Ramsay awards is their sheer breadth. Particularly with the 2019 awards, the Ramsays are dropping seeds across the biological...
Cytokines have been like a mirage in the desert for ME/CFS. These powerful immune factors seem like they must play a major role in this disease, but as soon as researchers have closed in on them, they’ve always seemed to slip away. A recent major review from the...
A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision. The study possibly identified...
